Designation / Description 2T8-3E10 MOUSE HYBRIDOMA (PATENT LINE)
U.S. Patent Number
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Animals were immunized with CT8III cells.
Spleen cells were fused with NS-1 myeloma cells.
The antibody does not react with human thymocytes or resting or activated peripheral T cells.
Shipped frozen
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation

Schlossman SF, et al. Monoclonal antibodies that recognize human T cells. US Patent 4,550,086 dated Oct 29 1985